CSI Market
Sign In | Register

American Oncology Network Inc (AONC) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access AONC Annual Cash Flow →
This cash flow overview for American Oncology Network Inc spans from Dec 31 2023 to Dec 31 2024, illustrating how cash generation and usage have shifted across recent reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
12 Months 		(Sep 30 2024) (Jun 30 2024) (Mar 31 2024) (Dec 31 2023)
Operating Activities
Income-26.96
Depreciation & amortization10.52
Amortization of Other Assets0.61
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-13.67
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property4.50
Share-based Compensation14.42
Income (Loss) from Equity Method Investments-0.15
Financial Instruments and Foreign Currency Transaction0.00
Investment Income Interest-
Unrealized Gain Loss On Marketable Securities Held In Trust Account-
Operating Lease Right Of Use Asset Amortization Expense6.39
Gain Loss On Warrant And Derivative Net-1.63
Increase Decrease In Operating Lease Liability-4.24
Amortization Of Post Combination Compensation0.88
Bargain Purchase Gain Loss On Acquisition Of Physician Practice-1.04
Bargain Purchase Gain Loss On Acquisition-0.32
Income taxes2.73
Losses/ -gains on Investments net0.00
Accounts Receivable-13.48
Increase (Decrease) in Accounts Payable39.49
Increase (Decrease) in Other Accrued Liabilities-6.11
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-3.96
Other Working Capital-15.71
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.24
Discontinued operations0.00
Net Cash flow from Operating Activities-4.94
Investing Activities
Capital Expenditures-20.95
Sale of Capital Items0.22
Proceeds from Sale of Available-for-sale Securities, Debt54.74
Payments to Acquire Available-for-sale Securities, Debt-28.64
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Gross-6.71
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables-1.06
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-2.41
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-3.50
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock49.63
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-3.26
Net Proceeds From Initial Public Offering-
Proceeds From Advance From Related Party-
Payments Of Preferred Returns And Tax Distributions-
Finance Lease Principal Payments-0.90
Business Combination To Reverse Recaptialization-
Business Combination To Reverse Recapitalization-
Payments For Debt Financing Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities41.66
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-25.68
Total Cash Flow34.31
4 historic quarters locked

Sign in to unlock the full American Oncology Network Inc cash flow history.

Sign In Create Free Account

About American Oncology Network Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20240930)
  • Filed with the SEC: November 13, 2024
  • Source: aonc-20240930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-24-047613

Figures are derived from filed reports and may be restated. Historical data is subject to revision.